Difference between revisions of "Thrombotic microangiopathy"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''") |
||
| Line 4: | Line 4: | ||
</div> | </div> | ||
{{#lst:Editorial board transclusions|heme}} | {{#lst:Editorial board transclusions|heme}} | ||
| − | * | + | *''We have moved [[How I Treat]] articles to a dedicated page.'' |
{| class="wikitable" style="float:right; margin-right: 5px;" | {| class="wikitable" style="float:right; margin-right: 5px;" | ||
|- | |- | ||
Latest revision as of 11:37, 15 May 2024
| Section editor | |
|---|---|
 |
Benjamin Tillman, MD Vanderbilt University Nashville, TN, USA |
- We have moved How I Treat articles to a dedicated page.
0 regimens on this page
0 variants on this page
|
Content to be added.